AI assistant
STRIDES PHARMA SCIENCE LIMITED — Board/Management Information 2025
Dec 3, 2025
62616_rns_2025-12-03_562eeae7-c026-4eb0-8e6e-798544b5e5f3.pdf
Board/Management Information
Open in viewerOpens in your device viewer
==> picture [143 x 47] intentionally omitted <==
December 3, 2025
BSE Limited
Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai – 400 001
The National Stock Exchange of India Limited Exchange Plaza, Bandra-Kurla Complex Bandra (E) Mumbai - 400 051
Scrip code: 532531
Scrip code: STAR
Dear Madam/ Sir,
Sub: Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Re: Exit of Group CHRO
We wish to inform you that Ms. Surabhi Loshali, Group CHRO of the Company, has resigned from Strides to pursue her personal and professional aspirations. Her last working day with Strides shall be closing business hours of January 2, 2026.
Surabhi has been associated with Strides over 5 years and assumed the role of Group CHRO effective June 1, 2024. Management places on record its appreciation for her valuable contributions and leadership during her tenure with the Company.
Surabhi’s resignation letter along with disclosures in the prescribed format is enclosed as an Annexure to this communication.
Re: Appointment of Executive VP - HR
Further, we are pleased to inform you that Ms. Nandini Matiyani has been appointed as Executive Vice President - Human Resources at the Company effective December 1, 2025.
Nandini is a HR leader with over 20 years of experience in driving people strategy and building highperformance cultures across multinational enterprises and publicly listed technology organizations. She brings expertise in areas such as people strategy, digital transformation, leadership succession, HR business partnering, talent acquisition, change management, diversity and inclusion, and HR technology and analytics.
This is for your information and records.
Thanks & Regards,
For Strides Pharma Science Limited,
Digitally signed by MANJULA R Date: 2025.12.03 11:38:11 MANJULA R +05'30'
Manjula Ramamurthy Company Secretary ICSI Membership No. A30515
Encl. As above
Strides Pharma Science Limited CIN: L24230MH1990PLC057062 Corp. Off: Strides House, Bilekahalli, Bannerghatta Road, Bengaluru - 560 076, India Tel: +91-80-6784 0000 Fax: +91 80 6784 0700 Regd Off: ‘ Cyber One’, Unit No. 902, Plot No. 4 & 6, Sector 30A, Vashi, Navi Mumbai - 400 703, India Tel: +91-22-2789 2924/ 3199 [email protected]; www.strides.com
Annexure A
==> picture [143 x 47] intentionally omitted <==
Exit of Ms. Surabhi Loshali, Group CHRO of the Company
| # | Details | Information of such event | |
|---|---|---|---|
| 1. | Reasons for change, viz., ~~appointment,~~resignation, ~~removal, death or otherwise~~ |
Ms. Surabhi Loshali, Group CHRO (Senior Management Personnel) of the Company, has resigned from Strides to peruse her personal and professional aspirations. Her last working day with Strides will be closing business hours of January 2, 2026. |
|
| 2. | Date of~~appointment/ re-~~ ~~appointment/~~cessation~~and~~ ~~term of appointment/ re-~~ ~~appointment~~ |
||
| 3. | Brief profile (in case of appointment) |
Not Applicable | |
| 4. | Disclosure of relationships between directors (in case of appointment of a director) |
Not Applicable |
Strides Pharma Science Limited CIN: L24230MH1990PLC057062 Corp. Off: Strides House, Bilekahalli, Bannerghatta Road, Bengaluru - 560 076, India Tel: +91-80-6784 0000 Fax: +91 80 6784 0700 Regd Off: ‘ Cyber One’, Unit No. 902, Plot No. 4 & 6, Sector 30A, Vashi, Navi Mumbai - 400 703, India Tel: +91-22-2789 2924/ 3199 [email protected]; www.strides.com
From: Surabhi Loshali Surabhi.Loshali@strides.com Sent: 06 October 2025 17:17 To: Badree Komandur Badree.Komandur@strides.com Subject: Resignation
Dear Badree,
As discussed, I hereby submit my formal resignation from the position of CHRO of Strides, and my last working day at Strides will be Friday, 2nd January 2026.
This decision has not been easy. However, the opportunity is such that it will help me grow professionally and will be more aligned to my personal needs. I am committed to ensuring transition during the notice period and assisting the Board and management in facilitating a seamless handover of duties and ongoing HR initiatives.
In line with the requirements for disclosure to stock exchanges and regulatory authorities, please regard this letter as my formal intimation to the Board of Directors and other relevant stakeholders. I trust that the company will announce the necessary disclosure in adherence to regulatory timelines and governance protocols.
I express my sincere gratitude for the opportunity to serve Strides, and for the support extended by Arun, you, the Board, and colleagues throughout my tenure. I remain confident in the company’s strategic direction and long-term growth prospects.
As discussed, I will keep it discreet between you and me until you are OK with sharing broadly.
Thanks and best regards, Surabhi